Seminars in Arthritis and Rheumatism
Volume 39, Issue 2 , Pages 71-80 , October 2009

Primary Osteoarthritis No Longer Primary: Three Subsets with Distinct Etiological, Clinical, and Therapeutic Characteristics

  • Gabriel Herrero-Beaumont, MD

      Affiliations

    • Bone and Joint Research Unit, Service of Rheumatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain
    • Corresponding Author InformationAddress reprint requests to Gabriel Herrero-Beaumont, MD, Bone and Joint Research Unit, Service of Rheumatology, Fundación Jiménez Díaz, Av. Reyes Católicos 2, 28040 Madrid, Spain
    • ,
  • Jorge A. Roman-Blas, MD

      Affiliations

    • Bone and Joint Research Unit, Service of Rheumatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain
    • Jefferson Institute of Molecular Medicine. Thomas Jefferson University, Philadelphia, PA
    • ,
  • Santos Castañeda, MD

      Affiliations

    • Department of Rheumatology, Hospital de la Princesa, Universidad Autónoma, Madrid, Spain
    • ,
  • Sergio A. Jimenez, MD

      Affiliations

    • Jefferson Institute of Molecular Medicine. Thomas Jefferson University, Philadelphia, PA

References 

  1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–656
  2. Elders MJ. The increasing impact of arthritis on public health. J Rheumatol. 2000;60(Suppl):6–8
  3. Martel-Pelletier J, Lajeunesse D, Fahmi H, Tardif G, Pelletier JP. New thoughts on the pathophysiology of osteoarthritis: one more step toward new therapeutic targets. Curr Rheumatol Rep. 2006;8:30–36
  4. Brandt KD, Radin EL, Dieppe PA, van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis. 2006;65:1261–1264
  5. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20:3–25
  6. Williams CJ, Jimenez SA. Skeletal dysplasias and the osteoarthritic phenotype. Best Pract Res Clin Rheumatol. 2003;17:1005–1018
  7. Jimenez SA, Dharmavaram RM. Genetic aspects of familial osteoarthritis. Ann Rheum Dis. 1994;53:789–797
  8. Knowlton RG, Katzenstein PL, Moskowitz RW, Weaver EJ, Malemud CJ, Pathria MN, et al. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med. 1990;322:526–530
  9. Ala-Kokko L, Baldwin CT, Moskowitz RW, Prockop DJ. Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci USA. 1990;87:6565–6568
  10. Williams CJ, Considine EL, Knowlton RG, Reginato A, Neumann G, Harrison D, et al. Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75 → Cys mutation in the procollagen type II gene (COL2A1). Hum Genet. 1993;92:499–505
  11. Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, Maguire JI, et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci USA. 1991;88:6624–6627
  12. Knowlton RG, Weaver EJ, Struyk AF, Knobloch WH, King RA, Norris K, et al. Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am J Hum Genet. 1989;45:681–688
  13. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet. 1995;10:330–336
  14. Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet. 1995;10:325–329
  15. Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, Zaucke F, et al. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem. 2006;281:32587–32595
  16. Stanescu R, Stanescu V, Mureil MP, Maroteaux P. Multiple epiphyseal dysplasia (Fairbank type: morphologic and biochemical study of cartilage). Am J Med Genet. 1993;45:501–507
  17. Maddox BK, Keene DR, Sakai LY, Charbonneau NL, Morris NP, Ridgeway CC, et al. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem. 1997;272:30993–30997
  18. Hecht JT, Deere M, Putnam E, Cole W, Vertel B, Chen H, et al. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol. 1998;17:269–278
  19. Hecht JT, Hayes E, Haynes R, Cole WG. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol. 2005;23:525–533
  20. Dinser R, Zaucke F, Kreppel F, Hultenby K, Kochanek S, Paulsson M, et al. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways. J Clin Invest. 2002;110:505–513
  21. Posey KL, Yang Y, Veerisetty AC, Sharan SK, Hecht JT. Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci. 2008;65:687–699
  22. van Mourik JB, Hamel BC, Mariman EC. A large family with multiple epiphyseal dysplasia linked to COL9A2 gene. Am J Med Genet. 1998;77:234–240
  23. Paassilta P, Lohiniva J, Annunen S, Bonaventure J, Merrer ML, Pai L, et al. COL9A3: A third locus for multiple epiphyseal dysplasia. Am J Hum Genet. 1999;64:1036–1044Erratum in: Am J Hum Genet 1999;65:1214
  24. Bönnemann CG, Cox GF, Shapiro F, Wu JJ, Feener CA, Thompson TG, et al. A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci USA. 2000;97:1212–1217
  25. Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perälä M, Carter L, et al. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am J Hum Genet. 2001;69:969–980
  26. Chapman KL, Mortier GR, Chapman K, Loughlin J, Grant ME, Briggs MD. Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet. 2001;28:393–396
  27. Kannu P, Bateman JF, Belluoccio D, Fosang AJ, Savarirayan R. Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis. Arthritis Rheum. 2009;60:325–334
  28. Valdes AM, Spector TD. The contribution of genes to osteoarthritis. Rheum Dis Clin North Am. 2008;34:581–603
  29. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S, et al. A functional polymorphism in the 5′-UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet. 2007;39:529–533
  30. Southam L, Rodriguez-Lopez J, Wilkins JM, Pombo-Suarez M, Snelling S, Gomez-Reino JJ, et al. An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet. 2007;16:2226–2232
  31. Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci USA. 2004;101:9757–9762
  32. Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, et al. Association of the frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum. 2005;52:1077–1080
  33. Lane NE, Lian K, Nevitt MC, Zmuda JM, Lui L, Li J, et al. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 2006;54:1246–1254
  34. Valdes AM, Loughlin J, Oene MV, Chapman K, Surdulescu GL, Doherty M, et al. Sex and ethnic differences in the association of ASPN (CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee). Arthritis Rheum. 2007;56:137–146
  35. Rodriguez-Lopez J, Pombo-Suarez M, Liz M, Gomez-Reino JJ, Gonzalez A. Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis. Ann Rheum Dis. 2007;66:1052–1055
  36. Meulenbelt I, Min JL, Bos S, Riyazi N, Houwing-Duistermaat JJ, van der Wijk HJ, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet. 2008;17:1867–1875
  37. Bos SD, Slagboom PE, Meulenbelt I. New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opin Rheumatol. 2008;20:553–559
  38. Sanna S, Jackson AU, Nagaraja R, Willer CJ, Chen WM, Bonnycastle LL, et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet. 2008;40:198–203
  39. Lories RJ, Peeters J, Bakker A, Tylzanowski P, Derese I, Schrooten J, et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 2007;56:4095–4103
  40. Mizuguchi T, Furuta I, Watanabe Y, Tsukamoto K, Tomita H, Tsujihata M, et al. LRP5, low-density-lipoprotein receptor related protein 5, is a determinant for bone mineral density. J Hum Genet. 2004;49:80–86
  41. Rosner IA, Manni A, Malemud CJ, Boja B, Moskowitz RM. Estradiol receptors in articular chondrocytes. Biochem Biophys Res Commun. 1982;106:1378–1382
  42. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage. 1999;7:560–566
  43. Braidman IP, Hainey L, Batra G, Selby PL, Saunders PT, Hoyland JA. Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res. 2001;16:214–220
  44. Dietrich W, Haitel A, Holzer G, Huber JC, Kolbus A, Tschugguel W. Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig. 2006;13:512–517
  45. Ushiyama T, Inoue K, Nishioka J. Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol. 1995;22:421–426
  46. Liu SH, al-Shaikh R, Panossian V, Yang RS, Nelson SD, Soleiman N, et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res. 1996;14:526–533
  47. Kahlert S, Grohé C, Karas RH, Löbbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem Biophys Res Commun. 1997;232:373–378
  48. Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 2002;30:18–25
  49. Richette P, Dumontier MF, Tahiri K, Widerak M, Torre A, Benallaoua M, et al. Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment. Ann Rheum Dis. 2007;66:345–350Erratum in: Ann Rheum Dis 2007;66:708
  50. McMillan J, Fatehi-Sedeh S, Sylvia VL, Bingham V, Zhong M, Boyan BD, et al. Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways. Biochem Biophys Acta. 2006;1763:381–392
  51. Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, et al. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti- versus pro-apoptotic effects of estrogens. J Biol Chem. 2005;280:4632–4638
  52. Boland R, Vasconsuelo A, Milanesi L, Ronda AC, de Boland AR. 17beta-Estradiol signaling in skeletal muscle cells and its relationship to apoptosis. Steroids. 2008;73:859–863
  53. Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, et al. Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem. 2007;282:20715–20727
  54. Heino TJ, Hentunen TA, Väänänen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem. 2002;85:185–197
  55. Maneix L, Beauchef G, Servent A, Wegrowski Y, Maquart FX, Boujrad N, et al. 17Beta-oestradiol up-regulates the expression of a functional UDP-glucose dehydrogenase in articular chondrocytes: comparison with effects of cytokines and growth factors. Rheumatology. 2008;47:281–288
  56. Mackintosh D, Mason RM. Pharmacological actions of 17 beta-oestradiol on articular cartilage chondrocytes and chondrosarcoma chondrocytes in the absence of oestrogen receptors. Biochem Biophys Acta. 1988;c964:c295–c302
  57. Talwar RM, Wong BS, Svoboda K, Harper RP. Effects of estrogen on chondrocyte proliferation and collagen synthesis in skeletally mature articular cartilage. J Oral Maxillofac Surg. 2006;64:600–609
  58. Ng MC, Harper RP, Le CT, Wong BS. Effects of estrogen on the condylar cartilage of the rat mandible in organ culture. J Oral Maxillofac Surg. 1999;57:818–823
  59. Sniekers YH, Weinans H, Bierma-Zeinstra SM, van Leeuwen JP, van Osch GJ. Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment—a systematic approach. Osteoarthritis Cartilage. 2008;16:533–541
  60. Høegh-Andersen P, Tankó LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther. 2004;6:R169–R180
  61. Dai G, Wang S, Li J, Liu C, Liu Q. The validity of osteoarthritis model induced by bilateral ovariectomy in guinea pig. Huazhong Univ Sci Technolog Med Sci. 2006;26:716–719
  62. Ham KD, Loeser RF, Lindgren BR, Carlson CS. Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum. 2002;46:1956–1964
  63. Ham KD, Carlson CS. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res. 2004;19:823–829
  64. Olson EJ, Lindgren BR, Carlson CS. Effects of long-term estrogen replacement therapy on bone turnover in periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys. Bone. 2008;42:907–913
  65. Castañeda S, Calvo E, Largo R, González-González R, de la Piedra C, Díaz-Curiel M, et al. Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab. 2008;26:53–59
  66. Calvo E, Castañeda S, Largo R, Fernández-Valle ME, Rodríguez-Salvanés F, Herrero-Beaumont G. Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage. 2007;15:69–77
  67. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3:716–724
  68. Loeser RF, Shakoor N. Aging or osteoarthritis: which is the problem?. Rheum Dis Clin North Am. 2003;29:653–673
  69. Loeser RF. Aging cartilage and osteoarthritis—what's the link?. Sci Aging Knowledge Environ. 2004;29:pe31
  70. Loeser RF. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 2006;54:1357–1360
  71. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci. 2005;62:2241–2256
  72. Verzijl N, Bank RA, TeKoppele JM, DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol. 2003;15:616–622
  73. Martin JA, Brown TD, Heiner AD, Buckwalter JA. Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res. 2004;427:S96–S103
  74. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213:626–634
  75. Yamada K, Healey R, Amiel D, Lotz M, Coutts R. Subchondral bone of the human knee joint in aging and osteoarthritis. Osteoarthritis Cartilage. 2002;10:360–369
  76. Degens H. Age-related skeletal muscle dysfunction: causes and mechanisms. J Musculoskelet Neuronal Interact. 2007;7:246–252
  77. Narici MV, Maffulli N, Maganaris CN. Ageing of human muscles and tendons. Disabil Rehabil. 2008;10:1–7
  78. Kellgren JH, Moore R. Generalized osteoathritis and Heberden's nodes. Br Med. 1952;1:181–187
  79. Stecher RM, Hersh AH, Hauser H. Heberden's nodes: the family history and radiographic appearance of a large family. Am J Hum Genet. 1953;5:46–69
  80. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ. 1996;312:940–943
  81. Hunter DJ, Snieder H, March L, Sambrook PN. Genetic contribution to cartilage volume in women: a classical twin study. Rheumatology. 2003;42:1495–1500
  82. Riyazi N, Meulenbelt I, Kroon HM, Ronday KH, Hellio le Graverand MP, Rosendaal FR, et al. Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study. Ann Rheum Dis. 2005;64:438–443
  83. Botha-Scheepers SA, Watt I, Slagboom E, Meulenbelt I, Rosendaal FR, Breedveld FC, et al. Influence of familial factors on radiologic disease progression over two years in siblings with osteoarthritis at multiple sites: a prospective longitudinal cohort study. Arthritis Rheum. 2007;57:626–632
  84. Zhai G, Hart DJ, Kato BS, MacGregor A, Spector TD. Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study. Osteoarthritis Cartilage. 2007;15:222–225
  85. Zhai G, Ding C, Stankovich J, Cicuttini F, Jones G. The genetic contribution to longitudinal changes in knee structure and muscle strength: a sibpair study. Arthritis Rheum. 2005;52:2830–2834
  86. Ikegawa S. New gene associations in osteoarthritis: what do they provide, and where are we going?. Curr Opin Rheumatol. 2007;19:429–434
  87. Ikegawa S. Genetic analysis of skeletal dysplasia: recent advances and perspectives in the postgenome-sequence era. J Hum Genet. 2006;51:581–586
  88. Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet. 2008;372:719–727
  89. Tilstra J, Rehman KK, Hennon T, Plevy SE, Clemens P, Robbins PD. Protein transduction: identification, characterization and optimization. Biochem Soc Trans. 2007;35:811–815
  90. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly (The Framingham Osteoarthritis Study). Arthritis Rheum. 1995;38:1500–1505
  91. Manninen P, Riihimaki H, Heliovaara M, Makela P. Overweight, gender and knee osteoarthritis. Int J Obes Relat Metab Disord. 1996;20:595–597
  92. Wilson MG, Michet CJ, Ilstrup DM, Melton LJ. Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study. Mayo Clin Proc. 1990;65:1214–1221
  93. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage. 2005;13:769–781
  94. Silman AJ, Newman J. Obstetric and gynaecological factors in susceptibility to peripheral joint osteoarthritis. Ann Rheum Dis. 1996;55:671–673
  95. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–799
  96. Wood P. Age and the rheumatic diseases. In:  Bennett PH,  Wood PH editor. Population Studies of the Rheumatic Diseases. vol. 4:Amsterdam: Excerpta Medica; 1982;p. 26–37
  97. Nadkar MY, Samant RS, Vaidya SS, Borges NE. Relationship between osteoarthritis of knee and menopause. J Assoc Phys India. 1999;47:1161–1163
  98. Sowers MR, McConnell D, Jannausch M, Buyuktur AG, Hochberg M, Jamadar DA. Estradiol and its metabolites and their association with knee osteoarthritis. Arthritis Rheum. 2006;54:2481–2487
  99. Bergink AP, van Meurs JB, Loughlin J, Arp PP, Fang Y, Hofman A, et al. Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum. 2003;48:1913–1922
  100. Valdes AM, Van Oene M, Hart DJ, Surdulescu GL, Loughlin J, Doherty M, et al. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum. 2006;54:533–539
  101. Jin SY, Hong SJ, Yang HI, Park SD, Yoo MC, Lee HJ, et al. Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population. Arthritis Res Ther. 2004;6:R415–R421
  102. Cooper C, Egger P, Coggon D, Hart DJ, Masud T, Cicuttini F, et al. Generalized osteoarthritis in women: pattern of joint involvement and approaches to definition for epidemiological studies. J Rheumatol. 1996;23:1938–1942
  103. Szoeke CE, Cicuttini FM, Guthrie JR, Clark MS, Dennerstein L. Factors affecting the prevalence of osteoarthritis in healthy middle-aged women: data from the longitudinal Melbourne Women's Midlife Health Project. Bone. 2006;39:1149–1155
  104. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis. 2001;60:332–336
  105. Rosner IA, Goldberg VM, Getzy L, Moskowitz RW. Effects of estrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum. 1979;22:52–58
  106. Rosner IA, Boja BA, Goldberg VM, Moskowitz RW. Tamoxifen therapy in experimental osteoarthritis. Curr Ther Res. 1983;34:409–414
  107. Colombo C, Butler M, Hickman L, Selwyn M, Chart J, Steinetz B. A new model of osteoarthritis in rabbits (II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically). Arthritis Rheum. 1983;26:1132–1139
  108. Tsai CL, Liu TK. Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen. Life Sci. 1992;50:1943–1951
  109. Christgau S, Tankó LB, Cloos PA, Mouritzen U, Christiansen C, Delaissé JM, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause. 2004;11:508–518
  110. Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D, et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum. 2004;50:3516–3525
  111. Ham KD, Carlson CS. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res. 2004;19:823–829
  112. Olson EJ, Lindgren BR, Carlson CS. Effects of long-term estrogen replacement therapy on the prevalence and area of periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys. Bone. 2007;41:282–289
  113. Olson EJ, Lindgren BR, Carlson CS. Effects of long-term estrogen replacement therapy on bone turnover in periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys. Bone. 2008;42:907–913
  114. Herndon JH. Osteoarthritis in women after menopause. Menopause. 2004;11:499–501
  115. Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol. 1998;10:269–272
  116. Punzi L, Ramonda R, Sfriso P. Erosive osteoarthritis. Best Pract Res Clin Rheumatol. 2004;18:739–758
  117. Sipilä S. Body composition and muscle performance during menopause and hormone replacement therapy. J Endocrinol Invest. 2003;26:893–901
  118. Slemenda C, Heilman DK, Brandt KD, Katz BP, Mazzuca SA, Braunstein EM, et al. Reduced quadriceps strength relative to body weight: a risk factor for knee osteoarthritis in women?. Arthritis Rheum. 1998;41:1951–1959
  119. Sipilä S, Poutamo J. Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women. Scand J Med Sci Sports. 2003;13:19–25
  120. Sharma L, Lou C, Felson DT, Dunlop DD, Kirwan-Mellis G, Hayes KW, et al. Laxity in healthy and osteoarthritic knees. Arthritis Rheum. 1999;42:861–870
  121. Spector TD, Nandra D, Hart DJ, Doyle DV. Is hormone replacement therapy protective for hand and knee osteoarthritis in women? (The Chingford Study). Ann Rheum Dis. 1997;56:432–444
  122. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis Study. Arthritis Rheum. 1990;33:525–532
  123. Taaffe DR, Sipilä S, Cheng S, Puolakka J, Toivanen J, Suominen H. The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin Physiol Funct Imaging. 2005;25:297–304
  124. Sipilä S, Taaffe DR, Cheng S, Puolakka J, Toivanen J, Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond). 2001;101:147–157
  125. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, et al. Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr. 2005;82:651–656
  126. Sugiura T, Ito N, Goto K, Naito H, Yoshioka T, Powers SK. Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats. J Physiol Sci. 2006;56:393–399
  127. Aigner T, Rose J, Martin J, Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res. 2004;7:134–145
  128. van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey (Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations). Ann Rheum Dis. 1989;48:271–280
  129. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001;60:91–97
  130. Bennell KL, Hunt MA, Wrigley TV, Lim BW, Hinman RS. Role of muscle in the genesis and management of knee osteoarthritis. Rheum Dis Clin North Am. 2008;34:731–754
  131. Hurley MV. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis Clin North Am. 1999;25:283–298
  132. Messier SP, Loeser RF, Hoover JL, Semble EL, Wise CM. Osteoarthritis of the knee: effects on gait, strength, and flexibility. Arch Phys Med Rehabil. 1992;73:29–36
  133. Suetta C, Aagaard P, Magnusson SP, Andersen LL, Sipilä S, Rosted A, et al. Muscle size, neuromuscular activation, and rapid force characteristics in elderly men and women: effects of unilateral long-term disuse due to hip-osteoarthritis. J Appl Physiol. 2007;102:942–948

 The authors declare they have no conflict of interests to disclose.

 Gabriel Herrero-Beaumont was supported by research grants from the Spanish Ministry of Education (SAF2006/2704).

PII: S0049-0172(09)00036-5

doi: 10.1016/j.semarthrit.2009.03.006

Seminars in Arthritis and Rheumatism
Volume 39, Issue 2 , Pages 71-80 , October 2009

Article Tools

* Image Usage & Resolution